MSH Publications on Tuberculosis

Our volume of peer-reviewed journal articles highlights MSH’s long-term commitment to ending the TB epidemic. Authored or co-authored by MSH technical experts over the last decade, these articles are important contributions to the evidence base of what works in the fight against TB, including systems strengthening innovations that improve access to both established and novel TB medicines, ensure safety and quality, and promote effective detection and case management.

Published in 2021

Prevalence of latent tuberculosis infection among health workers in Afghanistan: A cross-sectional study. PLOS One. 2021;16(6):e0252307. doi:10.1371/journal.pone.0252307

Shrestha S, Reja M, Gomes I, et al. Quantifying geographic heterogeneity in TB incidence and the potential impact of geographically targeted interventions in South and North City Corporations of Dhaka, Bangladesh: a model-based study. Epidemiology & Infection. 2021;149:e106. doi:10.1017/S0950268821000832

Tesema E, Wares F, Bedru A, et al. Experiences of introducing new drugs for drug-resistant TB at the ALERT Hospital, Addis Ababa, Ethiopia, 2017-2019. Public Health Action. 2021;11(2):50-52. doi:10.5588/pha.20.0065 

Published in 2020

Gomes I, Reja M, Shrestha S, et al. Incorporating patient reporting patterns to evaluate spatially targeted TB interventions. Annals of Epidemiology. 2021;54:7-10. doi:10.1016/j.annepidem.2020.11.003

Gous N, Nyaruhirira AU, Cunningham B, Macek C. Driving the usage of tuberculosis diagnostic data through capacity building in low- and middle-income countries. African Journal of Laboratory Medicine. 2020;9(2):1092. doi:10.4102/ajlm.v9i2.1092

Kasozi S, Kirirabwa NS, Kimuli D, et al. Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda. PLOS One. 2020;15(12):e0244451. doi:10.1371/journal.pone.0244451

Kassaw NA, Haidar J, Assefa D, et al. Bibliography of the Literatures on Tuberculosis, TB/HIV and MDR-TB in Ethiopia from 2001 – 2017. Ethiopian Journal of Health Sciences. 2020;30(si1):3. doi:

Ketema L, Dememew ZG, Assefa D, Gudina T, Kassa A, et al. Evaluating the integration of tuberculosis screening and contact investigation in tuberculosis clinics in Ethiopia: A mixed method study. PLOS One 15(11): e0241977.

Collins D, Lam H, Firdaus H, Antipolo J, Mangao P. Modeling the likely economic cost of non-adherence to TB medicines in the Philippines. International Journal of Tuberculosis and Lung Disease. 2020;24(9):902-9(8). doi:

Datiko DG, Hadgu A, Jerene D, Suarez P. High urban tuberculosis case notification rates can be misleading: evidence from an urban setting in Ethiopia. BMC Public Health. 2020;20(1):302. doi: 10.1186/s12889-020-8290-z.

Datiko DG, Jerene D, Suarez P. Patient and health system delay among TB patients in Ethiopia: nationwide mixed method cross-sectional study. BMC Public Health. 2020; 20(1126). doi:

Datiko DG, Jerene D, Suarez P. Stigma matters in ending tuberculosis: nationwide survey of stigma in Ethiopia. BMC Public Health. 2020; 29(190). doi: 10.1186/s12889-019-7915-6.

Dememew ZG, Jerene D, Datiko DG, Hiruy N, Tadesse A, Moile T, Bekele D, Yismawu G, Melkieneh K, Reshu B, Suarez PG. The yield of community-based tuberculosis and HIV among key populations in hotspot settings of Ethiopia: a cross-sectional implementation study. PLoS One. 2020. doi: 10.1371/journal.pone.0233730.

Habte D, et al. Factors determining treatment success in children with drug-sensitive tuberculosis in Ethiopia: a three-year retrospective analysis. American Journal of Tropical Medicine and Hygiene. 2020;00(0):1-5. doi: 10.4269/ajtmh.19-0816.

Ngabonziza JCS, et al. Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda. International Journal of Tuberculosis and Lung Disease. 2020;24(3):329-39. doi: 10.5588/ijtld.19.0298.

Active household contact screening for tuberculosis and provision of isoniazid preventive therapy to under-five children in Afghanistan. PLoS One. 2020;15(10):e0240031. doi:

Sosra A, Jerene D, Negash S, Habtamu A. Use of Xpert contributes to accurate diagnosis, timely initiation, and rational use of anti-TB treatment among childhood tuberculosis cases in south central Ethiopia. Pediatric Health, Medicine and Therapeutics. 2020;11:153-60. doi: 10.2147/PHMT.S244154.

Published in 2019

Alffenaar JC, Gumbo T, Dooley KE, Peloquin CA, McIlleron H, Zagorski A, et al. Integrating pharmacokinetics and pharmacodynamics in operational research to End TB. Clinical Infectious Diseases. 2019; pii:ciz942. doi: 10.1093/cid/ciz942.

Asres A, Jerene D, Deressa W. Delays to anti-tuberculosis treatment initiation among cases on directly observed treatment short course in districts of southwestern Ethiopia: a cross sectional study. BMC Infectious Diseases. 2019;19:418. doi:

Datiko DG, Habte D, Jerene D, Suarez P. Knowledge, attitudes, and practices related to TB among the general population of Ethiopia: Findings from a national cross-sectional survey. PLoS One. 2019; 14(10): e0224196.

Kirirabwa NS, Kimuli D, Nanziri C, Sama D, Ntudhu S, Okello DA, Byaruhanga R, Lukoye D, Kasozi S. A four-year trend in pulmonary bacteriologically confirmed tuberculosis case detection in Kampala, Uganda. BMC Pulmonary Medicine. 2019;19:91. doi: 10.1186/s12890-019-0853-3.

Lai J, Dememew Z, Jerene D, Abashawl A, Feleke B, Teklu AM, Ruff A. Provider barriers to the uptake of isoniazid preventive therapy among people living with HIV in Ethiopia. International Journal of Tuberculosis and Lung Disease. 2019;23(3):371-77. doi:

Prevalence of tuberculosis among mentally ill patients in conflict-stricken Afghanistan: a cross-sectional study. International Journal of Infectious Diseases. 2018; pii:S1201-9712(19)30346-7. doi: 10.1016/j.ijid.2019.08.020.

Verma M, et al. A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment. Science Translational Medicine. 2019; 11. doi: 10.1126/scitranslmed.aau6267

Published in 2018

Asres A, Jerene D, Deressa W. Delays to treatment initiation is associated with tuberculosis treatment outcomes among patients on directly observed treatment short course in Southwest Ethiopia: a follow-up study. BMC Pulmonary Medicine. 2018;18(1):64. doi: 10.1186/s12890-018-0628-2.

Asres A, Jerene D, Deressa W. Pre- and post-diagnosis costs of tuberculosis to patients on directly observed treatment short course in districts of Southwestern Ethiopia: a longitudinal study. Journal of Health, Population and Nutrition. 2018;37(1):15. doi:

Ayalew A, Gashu Z, Anteneh T, Hiruy N, Habte D, Jerene D, Alem G, Jemal I, Melese M, Suarez PG. Improvement in tuberculosis infection control practice via technical support in two regions of Ethiopia. BMC Infectious Diseases. 2018;18:557. doi:10.1186/s12879-018-3459-0.

Collins D, Beyene D, Tedla Y, Mesfin H, Diro E. Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia? International Journal of Tuberculosis and Lung Disease. 2018;22:905-11(7). doi:

Hiruy N, Melese MHabte DJerene DGashu ZAlem G. Comparison in the yield of tuberculosis among contacts of multidrug-resistant and drug-sensitive tuberculosis patients in Ethiopia using GeneXpert as a primary diagnostic test. International Journal of Infectious Diseases. 2018;71:4-8. doi: 10.1016/j.ijid.2018.03.011.

Melese M, Habte D, Girma B, Kassie Y, Negash S, Melkeneh K, et al. Use of indicators of standards of care to improve tuberculosis program management in Ethiopia. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2018;10:17-23. doi:

Kirirabwa NS, Kimuli D, DeJene S, Nanziri C, Birabwa E, Okello DA, Suarez PG, Kasozi S, Byaruhanga R, Lukoye D. Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda. PLoS One. 2018;13:e0208390. doi: 10.1371/journal.pone.0208390.

Namiiro S, Wobudeya E, Colebunders R, Worodria W. Molecular tests expedite the diagnosis of multidrug-resistant tuberculosis in childhood [letter]. International Journal of Tuberculosis and Lung Disease. 2018;22:349-50(2). doi:

Ogbudebe CL, Adepoju V, Ekerete-Udofia C, Abu E, Egesemba G, Chukwueme N, et al. Childhood tuberculosis in Nigeria: disease presentation and treatment outcomes. Health Services Insights. 2018;11:1-7. doi:

Published in 2017

Collins D, Hafidz F, Mustikawati D. The economic burden of tuberculosis in Indonesia. International Journal of Tuberculosis and Lung Disease. 2017;(9):1041-8. doi: 10.5588/ijtld.16.0898.

Jerene D,  Abebe W, Taye K, Suarez PG, Feleke Y, Hallström I, et al. Tuberculosis along the continuum of HIV care in a cohort of adolescents living with HIV in Ethiopia. International Journal of Tuberculosis and Lung Disease. 2017;21(1):32-7(6). doi:

Jerene D, Hiruy N, Jemal  I, Gebrekiros W, Anteneh T, Habte  D, et al. The yield and feasibility of integrated screening for TB, diabetes and HIV in four public hospitals in Ethiopia. International Health. 2017; 9(2): 100-4.

Konduri N, Delmotte E, Rutta E. Engagement of the private pharmaceutical sector for TB control: rhetoric or reality? Journal of Pharmaceutical Policy and Practice. 2017;10:6. doi: 10.1186/s40545-016-0093-3.

Konduri N, Bastos LGV, Sawyer K, Reciolino LFA. User experience analysis of an eHealth system for tuberculosis in resource-constrained settings: A nine-country comparison. International Journal of Medical Informatics. 2017;102:118-29. doi: 10.1016/j.ijmedinf.2017.03.017.

Konduri N, Sawyer K, Nizova N. User experience analysis of e-TB Manager, a nationwide electronic tuberculosis recording and reporting system in Ukraine. ERJ Open Research. 2017;3(2). pii: 00002-2017. doi: 10.1183/23120541.00002-2017.

Molla Y, Jerene D, Jemal I, Nigussie G, Kebede T, Kassie Y, et al. The experience of scaling up a decentralized, ambulatory model of care for management of multidrug-resistant tuberculosis in two regions of Ethiopia. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2017;7:28-33. doi: 10.1016/j.jctube.2017.03.001.

Tessema B, Moges F, Habte D, Hiruy N, Yismaw S, Melkieneh K, et al. Vitamin D deficiency among smear positive pulmonary tuberculosis patients and their tuberculosis negative household contacts in Northwest Ethiopia: a case-control study. Annals of Clinical Microbiology and Antimicrobials. 2017;16(1):36. doi: 10.1186/s12941-017-0211-3.

Wobudeya E, Sekadde-Kasirye M, Kimuli D, Mugabe F, Lukoye D. Trend and outcome of notified children with tuberculosis during 2011-2015 in Kampala, Uganda. BMC Public Health. 2017;17: 963. doi:

Published in 2016

Andre E, Isaacs C, Affolabi D, Alagna R, Brockmann D, de Jong BC, et al. Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination. International Journal of Tuberculosis and Lung Diseases. 2016;20(8):999-1003. doi: 10.5588/ijtld.16.0015.

Asres A, Jerene D, Deressa W. Tuberculosis treatment outcomes of six and eight month treatment regimens in districts of Southwestern Ethiopia: a comparative cross-sectional study. BMC Infectious Diseases. 2016;16: 653. doi: 10.1186/s12879-016-1917-0.

Dememew ZG, Melese M, Hiruy N, Girma B, Jerene D, Suarez P, et al. Trends in tuberculosis case notification and treatment outcomes after interventions in 10 zones of Ethiopia. International Journal of Tuberculosis and Lung Disease. 2016;20(9):1192-8. doi: 10.5588/ijtld.16.0005.

Falzon D, Timimi H, Kurosinski P, Migliori GB, Van Gemert W, Denkinger C, et al. Digital health for the End TB Strategy: developing priority products and making them work. European Respiratory Journal. 2016;48(1):29-45. doi:

Gashu Z, Jerene D, Ensermu M, Habte D, Melese M, Hiruy N, et al. The yield of community-based “retrospective” tuberculosis contact investigation in a high burden setting in Ethiopia. PLoS One. 2016. doi:

Habte D, Melese M, Hiruy N, Gashu Z, Jerene D, Moges F, et al. The additional yield of GeneXpert MTB/RIF test in the diagnosis of pulmonary tuberculosis among household contacts of smear positive TB cases. International Journal of Infectious Diseases. 2016;49:179-84. doi: 10.1016/j.ijid.2016.07.002.

Harries AD, Ford N, Jahn A, Schouten EJ, Libamba E, Chimbwandira F, et al. Act local, think global: How the Malawi experience of scaling up antiretroviral treatment has informed global policy. BMC Public Health. 2016;16(1):938. doi: 10.1186/s12889-016-3620-x.

Karmaker H, Basar MA, Karim MR, Rana MM, Hossain MG, Wadood MA. An epidemiological study of drug resistant tuberculosis cases: survey in the northern part of Bangladesh. Public Health Research 2016;6(2):52-8. doi: 10.5923/j.phr.20160602.04.

Lingaraju S, Rigouts L, Gupta A, Lee J, Umubyeyi AN, Davidow AL, et al. Geographic differences in the contribution of ubiA mutations to high-level ethambutol resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 2016;60(7):4101-5. doi: 10.1128/AAC.03002-15.

Melese M, Jerene D, Alem G, Seid J, Belachew F, Kassie Y, et al. Decentralization of acid fast bacilli (AFB) external quality assurance using blind rechecking for sputum smear microscopy in Ethiopia. PLoS One. 2016;11(3):e0151366. doi: 10.1371/journal.pone.0151366.

Ngabonziza JC, Ssengooba W, Mutua F, Torrea G, Dushime A, Gasana M, et al. Diagnostic performance of smear microscopy and incremental yield of Xpert in detection of pulmonary tuberculosis in Rwanda. BMC Infectious Diseases. 2016;16(1):660. doi: 10.1186/s12879-016-2009-x.

Simon GG. Impacts of neglected tropical disease on incidence and progression of HIV/AIDS, tuberculosis, and malaria: scientific links. International Journal of Infectious Diseases. 2016;42:54-7. doi: 10.1016/j.ijid.2015.11.006.

Tadesse Y, Gebre N, Daba S, Gashu Z, Habte D, Hiruy N, et al. Uptake of isoniazid preventive therapy among under-five children: TB contact investigation as an entry point. PLoS One. 2016;11 (5):e0155525. doi: 10.1371/journal.pone.0155525.

Telisinghe L, Charalambous S, Topp SM, Herce ME, Hoffmann CJ, Barron P, et al. HIV and tuberculosis in prisons in sub-Saharan Africa. The Lancet. 2016;388:17-23. doi: 10.1016/S0140-6736(16)30578-5.

Umubyeyi AN, Bonsu F, Chimzizi R, Jemal S, Melese M, Ruttoh E, et al. The role of technical assistance in expanding access to Xpert MTB/RIF: experience in sub-Saharan Africa. Public Health Action. 2016;6(1):32-4. doi:

van den Hof S, Collins D, Hafidz F, Beyene D, Tursynbayeva A, Tiemersma A. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan. BMC Infectious Diseases. 2016;16(1):470. doi: 10.1186/s12879-016-1802-x.

van Hoorn R, Jaramillo E, Collins D, Gebhard A, van den Hof S. The effects of psycho-emotional and socio-economic support for tuberculosis patients on treatment adherence and treatment outcomes: a systematic review and meta-analysis. PLoS One. 2016;11(4):e0154095. doi:


Published in 2015 

Jerene D, Melese M, Kassie Y, Alem G, Daba SH, Hiruye N, et al. The yield of a tuberculosis household contact investigation in two regions of Ethiopia. International Journal of TB and Lung Disease. 2015;19(8):898-903.

Lukoye D, Ssengooba W, Musisi K, Kasule GW, Cobelens FG, Joloba M, et al. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health. 2015;15(1):291. doi: 10.1186/s12889-015-1614-8.

Lunte K, Cordier-Lassalle T, Keravec J. Reducing the price of treatment for multidrug-resistant tuberculosis through the Global Drug Facility. Bulletin of the WHO. 2015;93:279-82. doi:

Malhotra S, Ursu I, Ghoneim R, Paredes Jodrey P, Brown MS, Barr-DiChiara M. From availability to uptake: planning for the introduction of new, child-friendly anti-tuberculosis formulations. International Journal of Tuberculosis and Lung Disease. 2015;19(12):Suppl 1:32-S38. doi:

Mekonnen, F. Multidrug resistant tuberculosis: prevalence and risk factors in districts of Metema and West Armachiho, Northwest Ethiopia. BMC Infectious Diseases. 2015;15:461. doi: 10.1186/s12879-015-1202-7.

Nabukenya-Mudiope MG,Kawuma HJ, Brouwer M, Mudiope P, Vassall A. Tuberculosis retreatment “others” in comparison with classical retreatment cases: a retrospective cohort review. BMC Public Health. 2015;15:840. doi: 10.1186/s12889-015-2195-2.

Nyaruhirira AU, Toussaint M, Nemser B, Vandebriel G, Gasana M, Ben Amor Y. Performance of LED fluorescence microscopy for the detection of tuberculosis in Rwanda using Zeiss Primo Star. Pan African Medical Journal. 2015;21:198. doi: 10.11604/pamj.2015.21.198.5776.

Addressing tuberculosis control in fragile states: urban DOTS experience in Kabul, Afghanistan, 2009-2015. PLoS One. 2017;12(5):e0178053.

Titiyos A, Jerene D, Enquselasie F. The yield of screening symptomatic contacts of multidrug-resistant tuberculosis cases at a tertiary hospital in Addis Ababa, Ethiopia. BMC Research Notes. 2015;8:501. doi: 10.1186/s13104-015-1442-z

Wobudeya E, Lukoye D, Lubega IR, Mugabe F, Sekadde M, Musoke P. Epidemiology of tuberculosis in children in Kampala district, Uganda, 2009–2010: a retrospective cross-sectional study. BMC Public Health. 2015;15:967. doi: 10.1186/s12889-015-2312-2.


Published in 2014

Abouyannis M, Dacombe R, Dambe I, Mpunga J, Faragher B, Gausi F et al. Drug resistance of Mycobacterium tuberculosis in Malawi: a cross-sectional survey. Bulletin of the WHO. 2014;92:798-806. doi:

Gebregergs GB, Alemneh M, Koye DN, Kassie Y, Assefa M, Ayalew W, et al. Poor symptomatic tuberculosis screening practices in a quarter of health centers in Amhara Region, Ethiopia. Public Health Action. 2014;4 Suppl 3. doi: 10.5588/pha.14.0053.

Olakunle, OS, Oladimeji O, Olalekan AW, Olugbenga-Bello A, Akinleye C, Oluwatoyin OA. Knowledge of tuberculosis management using directly observed treatment short course therapy among final year medical students in South Western Nigeria. Pan African Medical Journal. 2014;18:32. doi: 10.11604/pamj.2014.18.32.3553.

Rutta E, Delmotte E, Mwakisu S, Konduri N, Kakanda K, Valimba R. Understanding private retail drug outlet dispenser knowledge and practices in tuberculosis care in Tanzania. International Journal of Tuberculosis and Lung Disease. 2014;18(9):1108-13. doi:

Westerlund E, Jerene D, Mulissa Z, Hallström I, Lindtjørn B. Pre-ART retention in care and prevalence of tuberculosis among HIV-infected children at a district hospital in southern Ethiopia. BMC Pediatrics. 2014;14:250. doi:


Published in 2013

Gemal A, Keravec J, Menezes A, Trajman A. Can Brazil play a more important role in global tuberculosis drug production? An assessment of current capacity and challenges. BMC Public Health. 2013;13:279. doi:

Hirpa S, Medhin G, Girma B, Melese M, Mekonen A, Suarez P, et al. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa. BMC Public Health. 2013;13(1):782. doi:

Kibret KT, Alemayehu WY, Belaineh GB, Muluken MA. Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa Ethiopia: a case control study. PLoS One. 2013;8(5):e64488. doi:

Mauch V, Bonsu F, Gyapong M, Awini E, Suarez P, Marcelino B, et al. Free tuberculosis diagnosis and treatment are not enough: Patient cost evidence from three continents. International Journal of Tuberculosis and Lung Disease. 2013;17(3):381-7. doi:

Mauch V, Melgen R, Marcelino B, Acosta I, Klinkenberg E, Suarez P. Tuberculosis patients in the Dominican Republic face severe direct and indirect costs and need social protection. Revista Panamericana de Salud Pública. 2013;33:332-9.

Mitnick CD, Keravec J. Planning for the invisible: projecting resources needed to identify and treat all patients with MDR-TB. International Journal of Tuberculosis and Lung Disease.  2013;17(4):427-8. doi:

Sileshi B, Deyessa N, Girma B, Melese M, Suarez P. Predictors of mortality among TB-HIV co-infected patients being treated for tuberculosis in northwest Ethiopia: a retrospective cohort study. BMC Infectious Diseases. 2013;13:297. doi: 10.1186/1471-2334-13-297.

Vianzon R, Garfin AMC, Lagos A, Belen R. The tuberculosis profile of the Philippines, 2003-2011: advancing DOTS and beyond. Western Pacific Surveillance and Response Journal. 2013;4(2):11-16. doi: 10.5365/wpsar.2012.3.4.022.


Published in 2012

Daniel G, Tegegnework H, Demissie T, Reithinger R. Pilot assessment of supply chains for pharmaceuticals and medical commodities for malaria, tuberculosis and HIV infection in Ethiopia. Transactions of the Royal Society for Tropical Medicine and Hygiene. 2012;106(1): 60-2. doi:

Gafirita J, Umubyeyi AN, Asiimwe BB. A first insight into the genotypic diversity of Mycobacterium tuberculosis from Rwanda. BMC Clinical Pathology. 2012;12:20. doi: 10.1186/1472-6890-12-20.

Sagwa E, Mantel-Teeuwisse AK, Ruswa N, Musasa JP, Pal S, Dhliwayo P, et al. The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia. Southern Medical Review. 2012;5(1):6-13.

Saito S, Howard AA, Reid MJ, Elul B, Scardigli A, Verkuijl S, et al. TB diagnostic capacity in sub-Saharan African HIV care settings. Journal of Acquired Immune Deficiency Syndromes. 2012;61(2):216-20. doi: 10.1097/QAI.0b013e3182638ec7.

Tadeg H, Berhane Y. Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries. East African Journal of Public Health. 2012; 9(2):85-9.


Published in 2011

Falzon D, Jaramillo E, Schünemann HJ, Arentz M, Bauer M, Bayona J, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. European Respiratory Journal. 2011;38(3):516-28. doi: 10.1183/09031936.00073611.

Harries AD, Zachariah R, Chimzizi R, Salaniponi F, Gausi F, Kanyerere H, Schouten EJ, et al. Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with TB and HIV. BMC Public Health. 2011;11(593). doi: 10.1186/1471-2458-11-593.

Wells WA, Konduri N, Chen C, Lee D, Ignatius HR, Gardiner E, et al. Implications of the current TB treatment landscape for future regimen change. International Journal of Tuberculosis and Lung Disease. 2011;15(6):746-53. doi: 10.5588/ijtld.10.0094


Published in 2010

Wells WA, Konduri N, Lee D, Ignatius HR, Gardiner E, et al. TB regimen change in the high burden countries. International Journal of Tuberculosis and Lung Disease. 2010;14(12):1538-47. doi:


Published in 2009

Ngadaya ES, Mfinanga GS, Wandwalo ER, Morkve O. Delay in tuberculosis case detection in Pwani Region, Tanzania: a cross-sectional study. BMC Health Services Research. 2009;9:196. doi: 10.1186/1472-6963-9-196

Ngadaya ES, Mfinanga GS, Wandwalo ER, Morkve O. Pulmonary tuberculosis among women with cough attending clinics for family planning and maternal and child health in Dar Es Salaam, Tanzania. BMC Public Health. 2009;9:278. doi: 10.1186/1471-2458-9-278.


Published in 2008

Scaling up TB DOTS in a fragile state: post-conflict Afghanistan. International Journal of Tuberculosis and Lung Diseases. 2008;12(2):180-5.


View as a compilation PDF